TC
JAZZ icon

TownSquare Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

TownSquare Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,966
Closed -$492K – 1134
2025
Q1 		$492K Buy
3,966
+426
+12% +$55.6K 0.01% 1135
2024
Q4 		$436K Buy
3,540
+1,568
+80% +$185K ﹤0.01% 1083
2024
Q3 		$220K Buy
+1,972
New +$216K ﹤0.01% 1343
2020
Q2 		– Sell
-4,151
Closed -$455K – 423
2020
Q1 		$455K Buy
4,151
+847
+26% +$110K 0.04% 294
2019
Q4 		$492K Buy
3,304
+289
+10% +$39.3K 0.04% 283
2019
Q3 		$380K Buy
3,015
+260
+9% +$34.9K 0.03% 348
2019
Q2 		$385K Sell
2,755
-83
-3% -$11.2K 0.04% 327
2019
Q1 		$406K Buy
2,838
+740
+35% +$96.5K 0.03% 308
2018
Q4 		$270K Buy
+2,098
New +$311K 0.04% 309

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TownSquare Capital's JAZZ Position: Q2 2025 in Review

TownSquare Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 3,966 shares — an estimated $492K sold.

TownSquare Capital first reported a position in JAZZ in Q4 2018 and held it in 9 quarters. The position peaked at $492K in Q1 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • TownSquare Capital reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 3,966 Jazz Pharmaceuticals shares in Q2 2025, an estimated $492K.
  • TownSquare Capital first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 9 quarters.
  • TownSquare Capital's Jazz Pharmaceuticals position peaked at $492K in Q1 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.